FDA Approves ADAPALENE — Walgreens
Walgreens received FDA approval on June 2 for a generic topical acne treatment containing Adapalene, a move expected to intensify competition and price pressures within the dermatology market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day